I. Ramirez

发表

Effective therapy for Burkitt's lymphoma: High-dose cyclophosphamide + high-dose methotrexate with coordinated intrathecal therapy

J. Butler, M. Sullivan, J. J. Butler, 1979, Cancer Chemotherapy and Pharmacology.

Clofarabine, a novel nucleoside analog, is active in pediatric patients with advanced leukemia.

H. Kantarjian, W. Plunkett, M. Keating, 2004, Blood.

Curability of Burkitt's lymphoma with high-dose cyclophosphamide-high-dose methotrexate therapy and intrathecal chemoprophylaxis.

M. Sullivan, I. Ramirez, 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Severe osteopenia and vertebral compression fractures after complete remission in an adolescent with acute leukemia

R. Vassilopoulou-sellin, I. Ramirez, 1992, American journal of hematology.

Pilot studies of species-specific chemotherapy of childhood acute lymphoblastic leukemia using genotype and immunophenotype

D. Pinkel, J. Mullins, I. Ramirez, 2000, Leukemia.

Clinical and biological heterogeneity of childhood B cell acute lymphocytic leukemia: implications for clinical trials.

J. Shuster, M. Borowitz, D. Head, 1990, Leukemia.

Establishment and characterization of human B-cell lymphoma cell lines using B-cell growth factor

F. Cabanillas, A. Goodacre, R. Ford, 1990 .

advanced leukemia Clofarabine, a novel nucleoside analog, is active in pediatric patients with

H. Kantarjian, W. Plunkett, M. Keating, 2013 .

Second malignant neoplasm in treated Hodgkin's disease. Report of a patient and scope of the problem.

K. Cleary, J. Eys, J. van Eys, 1986, American journal of diseases of children.

High-dose mercaptopurine and intermediate-dose cytarabine during first remission of acute myeloid leukemia.

C. Canpolat, S. Jeha, D. Pinkel, 1997, Cancer Investigation.

High-dose mercaptopurine followed by intermediate-dose cytarabine in relapsed acute leukemia.

W. Plunkett, A. Cork, S. Jeha, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Results of a changing treatment philosophy for children with stage I Hodgkin's disease: a 35-year experience.

A. Garden, L. Fuller, S. Woo, 1991, Medical and pediatric oncology.

Establishment and characterization of human B-cell lymphoma cell lines using B-cell growth factor.

F. Cabanillas, A. Goodacre, S. Mehta, 1990, Blood.

Safety and efficacy of pegfilgrastim in pediatric oncology patients: The M.D. Anderson Cancer Center experience.

N. Jaffe, C. Herzog, S. Koontz, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

188Re-labeled anti-epidermal growth factor receptor humanized monoclonal antibody h-R3: labeling conditions, in vitro and in vivo stability.

N. Iznaga-Escobar, L. Suarez, I. Ramirez, 2003, Methods and findings in experimental and clinical pharmacology.